Investigation summary: based on the information available, there was no device available for analysis and there was no report of a device performance allegation during treatment.The reported necrosis is a known risk associated with penile prosthesis procedures and is noted as such in the instructions for use (ifu).Dhr review: review of manufacturing documentation was performed to ensure that all required in-process and final inspections and testing were completed.Review of the manufacturing records found no evidence that the device failed to meet applicable product specifications prior to shipment from boston scientific.Device technical analysis: the device is not available for analysis; therefore, no physical or visual analysis of the product could be performed.Labeling review: the tactra instructions for use (ifu) was reviewed.The patient symptom of necrosis was found to be listed in the ifu.Medical review assessment determined the data reasonably suggest the clinical event is anticipated in nature and severity as per the ifu and hazard analysis (ha).Investigation conclusion: based on the information available, a conclusion code of known inherent risk of device was assigned to this investigation.
|